Tacrolimus en el tratamiento de la proteinuria de difícil manejo asociada a la Nefritis lúpica. Experiencia de 3 centros.

Autores/as

  • Cristobal Oyarzún Kuschel Hospital Base Osorno. Universidad Austral de Chile
  • Maria Sonia Arriagada Herrera Hospital Base Osorno. Universidad Austral de Chile
  • Andrea Bancalari Selman Hospital Guillermo Grant de Concepción
  • Lorena Soto Horta Complejo Asistencial Dr. Víctor Ríos Ruíz de los Ángeles
  • Leonidas Llanos Saavedra Complejo Asistencial Dr. Víctor Ríos Ruíz de los Ángeles

Palabras clave:

Nefrítis Lúpica, Proteinuria, Tacrolimus

Resumen

The management of proteinuria in patients with lupus nephritis represents a challenge for the specialist. Recently, Calcineurin Inhibitors have been positioned as an effective alternative in these patients, but their use is not widespread in our country. We report the experience
of three centers in this regard.

Methods: a review of lupus nephritis patients treated with Tacrolimus from 3 centers in southern Chile. 

Results: Data from 10 patients with Lupus nephritis were obtained. All of them had significant proteinuria after the traditional induction scheme. In most of them, there was a significant decrease in proteinuria without deterioration of creatinine at 12 months after treatment with Tacrolimus alone or in combination with Mycophenolate.

Conclusions: Tacrolimus alone or in combination with Mycophenolate is a safe and effective alternative in the management of Lupus nephritis-associated proteinuria.

Descargas

Publicado

2024-10-10

Cómo citar

Oyarzún Kuschel, C., Arriagada Herrera, M. S., Bancalari Selman, A., Soto Horta, L., & Llanos Saavedra, L. (2024). Tacrolimus en el tratamiento de la proteinuria de difícil manejo asociada a la Nefritis lúpica. Experiencia de 3 centros. Revista Médica De Chile, 152(05). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/10692

Número

Sección

Comunicación Breve